If unorthodoxy and discipline could be blended and bottled, Bob Duggan would have another multibillion-dollar product. For now, his fortunes are focused on an experimental cancer drug that wowed ...

Many Kiwis will be feeling relief today as new Pharmac funded drugs officially become available, with Continuous Glucose ...

“When our Government assumed office, New Zealanders were facing an uncertain future for medicine access. Pharmac had a $1.7 billion funding hole and had no new money to increase access for medicines.

And 1 October means families can claim the new childcare payment FamilyBoost that we announced in the Budget. This gives eligible parents a refund of 25 per cent of the Early Childhood Education (ECE) ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

It is the first of a slew of cancer drugs to now funded by Pharmac following the agency's multi-million dollar budget boost.

After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The market could potentially see the emergence of new biotech industry leaders. Since the year started, Viking Therapeutics ...

The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.